Sector: Life Sciences

Latest content

Eligibility and PTAB reform bills spark debate at IAM event

IAM Connect: Patent Policy and Litigation delved deeply into Section 101 legislation, reform efforts at the Patent Trial and Appeal Board, and reactions to the European Commission's SEP proposal

23 November 2023

Key Moderna mRNA patent invalidated by EPO

The revocation has major implications for the covid-19 vaccine patent wars

21 November 2023

Qualcomm leads Brazilian patent filings this year

Clarivate data covering 2018 to 2023 reveals a dynamic landscape, including booming industries and Lenovo’s entry into the top 100

17 November 2023

Historic CRISPR drug approval heralds new era in Cas9 IP wars

Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.

17 November 2023

Regeneron asserts swathe of patents in latest Eylea biosimilar clash

Lawsuit is latest in a torrent of new BPCIA lawsuits to emerge over the past year

16 November 2023

The EU should listen to its Nordic champions, not ignore them

When companies with the innovation and tech leadership credentials of Ericsson, Nokia and Novo Nordisk raise major concerns about Commission proposals, their arguments deserve serious consideration. But it’s not happening. No wonder Europe is losing the global competition race

15 November 2023

Bristol-Myers fighting intense battle to keep Eliquis generics off European markets

What you need to know about one of 2023's most important patent wars

14 November 2023

Chinese patent office hands down key ruling on pharma patent requirements

Two recent invalidation decisions shed light on how China’s patent re-examination board considers the disclosure of experimental data when considering priority

14 November 2023

FTC challenges 100 patent listings, tightening screws on pharma companies

The commission recently vowed to take action on alleged anticompetitive IP tactics

13 November 2023

German Stelara injunction is bad news for biosimilars using the EU SPC manufacturing waiver

Munich Regional Court has become the first to wade in on disputes over drugs exports under Europe’s SPC exemption

06 November 2023

Unlock unlimited access to all IAM content